cbdMD (NYSEAMERICAN:YCBD) Trading 11.9% Higher – What’s Next?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s stock price was up 11.9% during mid-day trading on Monday . The stock traded as high as $0.7930 and last traded at $0.7608. Approximately 1,176,922 shares changed hands during mid-day trading, an increase of 161% from the average daily volume of 450,579 shares. The stock had previously closed at $0.68.

cbdMD Price Performance

The stock has a 50 day moving average price of $0.83 and a 200 day moving average price of $0.92.

Hedge Funds Weigh In On cbdMD

An institutional investor recently bought a new position in cbdMD stock. Jane Street Group LLC bought a new stake in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned approximately 0.49% of cbdMD at the end of the most recent quarter. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.